Close Menu
Home » Syapse Expands Into Asia With Korean Hospital Deal

Syapse Expands Into Asia With Korean Hospital Deal

Jan 31, 2018
|
staff reporter

CHICAGO (GenomeWeb) – Syapse, a maker of software to support precision oncology care, has entered the Asian market through a partnership with Seoul National University Hospital. A parallel deal with cloud IT company Megazone will allow the company to reach other potential customers in South Korea, Japan, and Vietnam.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Letting Samples Fly

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Layoffs at 23andMe

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Dusty Resistance

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

Science Studies Use Single-Cell RNA Sequencing to Study Cell States, Apply Deep Phenotyping to Pregnancy

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more. 

Feb
20
Featured Webinar

Advances in NGS Gene Expression Studies to Reduce The Cost of Sequencing

Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.

What's Popular?

In Informatics

  1. Quest Diagnostics Acquires Blueprint Genetics

  2. Predictive Oncology to Acquire Quantitative Medicine

  3. Multi-Disease Diagnostic Platform Project Receives €22.5M in EU Funding

  4. Evotec, Indivumed to Collaborate on Non-Small Cell Lung Cancer Drug Discovery

  5. LifeOmic, IU's Komen Tissue Bank Integrate Platforms to Further Breast Cancer Research

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.